Mass screening for hepatitis B and C in Southern Upper Egypt
Abstract Background It is well documented that Egypt has the highest prevalence of hepatitis C virus (HCV) infection in the world. The recent development of highly effective direct acting antiviral drugs (DAAs), has opened the possibility of treating and curing HCV infection in the Egyptian populati...
Saved in:
Main Authors: | Gamal Soliman (Author), Mahmoud S. Elzalabany (Author), Tarek Hassanein (Author), F. DeWolfe Miller (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of EGCRISC application versus hepatitis C virus mass screening in Egypt
by: Engy M. El-Ghitany
Published: (2019) -
Diagnostic challenges of tuberculosis peritonitis in upper Egypt
by: Nahed A Makhlouf, et al.
Published: (2016) -
Clinical, laboratory, and virological characteristics of patients with positive hepatitis B surface antigen in Upper Egypt
by: Khairy H Morsy, et al.
Published: (2015) -
Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: Enablers and obstacles
by: Hend Ibrahim Shousha, et al.
Published: (2020) -
Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features
by: Nahed A. Makhlouf, et al.
Published: (2019)